We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Peritoneal Dialysis Versus Haemodialysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00752583
Recruitment Status : Unknown
Verified December 2014 by University Hospital, Ghent.
Recruitment status was:  Recruiting
First Posted : September 15, 2008
Last Update Posted : December 5, 2014
Information provided by (Responsible Party):
University Hospital, Ghent

Brief Summary:
Study in order to quantify toxin removal during dialysis

Condition or disease Intervention/treatment
Hemodialysis Procedure: Peritoneal dialysis Procedure: Haemodialysis

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 75 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Study in Order to Quantify Solute Removal in Peritoneal Dialysis Versus Haemodialysis
Study Start Date : September 2008
Estimated Primary Completion Date : May 2015
Estimated Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Peritoneal dialysis
Procedure: Peritoneal dialysis
Blood, urine and dialysate sampling
Active Comparator: 2
Procedure: Haemodialysis
Blood, urine and dialysate sampling

Primary Outcome Measures :
  1. Registration of toxin removal efficiency [ Time Frame: After 1 week and after 1, 3, 6, 9, 12, 18 and 24 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Substudy 1: includes new starting dialysis patients on peritoneal dialysis PD or haemodialysis HD
  • Substudy 2: stabile haemodialysis patients and peritoneal dialysis patients. Patients will be matched for gender, time on dialysis, diabetes, renal function at the start of dialysis.
  • Substudy 3: patients on CAPD (continuous ambulant PD) or CCPD (continuous cyclic PD).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00752583

Contact: Sunny Eloot, PhD Sunny.eloot@ugent.be

University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Principal Investigator: Raymond Vanholder, MD, PhD         
Sub-Investigator: Sunny Eloot, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent

Additional Information:
Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00752583     History of Changes
Other Study ID Numbers: 2008/232
First Posted: September 15, 2008    Key Record Dates
Last Update Posted: December 5, 2014
Last Verified: December 2014

Keywords provided by University Hospital, Ghent:
Chronic renal insufficiency (patients under dialysis)